RE: estimated global availability of new repurposed therapies for COVID197 Jun 2021 14:56
Mikep109
Oakleaf72
:)
ask him why he did not chose to include any type of INF in the analysis
Corresponding author:
Dr Andrew Hill PhD
Department of Pharmacology and Therapeutics
University of Liverpool,
70 Pembroke Place
Liverpool L69 3GF, UK
Email: microhaart@aol.com
think,
lot of you knew this report Posted June 03, 2021
but kept quite